Bookmark Website  | Free Registration  | The Team
The Lounge  | Champions  | The Wire |  Schedule |  Audio  |  Arcade  |  The Top Ten  |  Historical  |  Email  |  Video

Reviving Vitamin E Studies That Challenge Claims of Wonder Supplement Also Leave Openings


The last year hasn't been a good one for vitamin E.

Once considered a wonder supplement, an inexpensive and harmless pill that might prevent heart disease, cancer and Alzheimer's, a flurry of recent clinical trials suggest it does none of those things.

Some even suggest there is a small chance it could be harmful in higher doses.

Yet while the oily little capsule apparently can't keep people alive longer, it refuses to die, in part because in nearly every one of the recent negative studies some caveat or contradictory finding creates a glimmer of hope.

It also doesn't hurt that the dietary supplement industry continues to promote vitamin E and offers experts to refute some of new research.

"It doesn't go away," said Edgar Miller, a vitamin E researcher and associate professor of medicine at Johns Hopkins University. "Why does it keep selling when there are so many of these negative studies?"

The answer appears to be a combination of factors, including years of promising laboratory, animal and epidemiological studies; heavy promotion by the dietary supplement industry; and, more recently, contradictory findings within studies showing no overall benefit.

The required daily amount is 22 IU (international units). Many recent clinical trials have ranged from 300 IU to 2,000 IU.

Recent clinical trials of high-dose vitamin E have led some researchers to speculate that vitamin E in megadoses may increase the oxidation of LDL cholesterol, the bad kind.

When cholesterol is oxidated, it contributes to coronary artery disease.

There also is some concern that high amounts of vitamin E may displace other beneficial anti-oxidants from that average person's diet.

Combining studies

Consider these recent studies: In November, a vitamin E bombshell was dropped by Johns Hopkins University researchers at an American Heart Association meeting.

They pooled 19 clinical trials of vitamin E involving 136,000 patients.

In 11 of the high-dose trials (400 IU or more), the risk of dying from any cause increased 4%, compared with people taking placebos.

Prior to that finding, vitamin E had been considered, at worst, harmless.

"People take anti-oxidants because they want to live longer," said Miller, an associate professor of medicine. "What we showed is you don't live longer."

However, the analysis also suggested that lower doses of vitamin E (less than 150 I.U. a day) were associated with about a 2% reduction in deaths.

Researchers acknowledged several potential shortcomings in their study.

For instance, they noted that several of the high-dose trials involved people with various chronic diseases and may not apply to healthy individuals.

They also said the small size of several of the trials in the analysis and inconsistent reporting of health events prevented a detailed look at the effect of various doses of the vitamin.

"It's a very flawed analysis," said Julie Buring, a professor of medicine at Harvard Medical School who recently presented her own vitamin E research.

She also said the 4% increased risk of death was not "clinically meaningful" and could be a chance finding.

Women's health study

On March 7, Buring and other Harvard scientists presented their own vitamin E study at the American College of Cardiology annual meeting.

Once again, the vitamin threw researchers a curve.

Analyzing data from the Women's Health Study, a trial involving 40,000 women who got either 600 IU of vitamin E every other day or a placebo, researchers found that it provided no overall cardiovascular benefit such as reduction in heart attacks or strokes.

However, an analysis of a subgroup of women over 65 found a 26% reduction in cardiovascular events.

Buring said that although the finding was "intriguing," it was not supported by previous research.

She added that it needs confirmation.

Adding even more confusion, the study found a statistically significant 24% reduction in cardiovascular deaths among all the vitamin E users.

Buring also questioned that finding because there was no overall reduction in strokes and heart attacks. She said it was possible that it was due to other cardiovascular causes such as arrhythmias or heart failure, but there was no reasonable biological explanation for that.

"People should look at that further, but it could be chance," she said.

Buring concluded that vitamin E was neither harmful nor beneficial in preventing cardiovascular disease.

A surprise

About a week after the Women's Health Study, another controversial vitamin E finding was presented.

The study involved 9,500 people aged 55 and older with vascular disease or diabetes who were followed for an average of seven years.

It found that 400 IU of vitamin E a day provided no protection against cancer or major vascular events such as heart attacks or strokes.

In addition, the study found a disturbing 13% increase in heart failure cases and 21% increase in heart failure hospitalizations.

That was the first time that vitamin E had been associated with an increased risk of heart failure, said lead author Eva Lonn, a professor of medicine at McMaster University in Hamilton, Ontario.

"I am not convinced about the harm," Lonn added.

Indeed, a recent small study of heart failure patients taking a cholesterol-lowering statin drug suggested that vitamin E actually increased the statin's ability to improve blood vessel function and lower inflammation.

Lonn and the other researchers said a review of all heart failure events in large vitamin E clinical trials "is strongly recommended."

Confounding the heart failure finding was what appeared to be a statistically significant 28% reduction in lung cancer cases, although in a secondary analysis of the data the benefit seemed to disappear.

"The numbers are small," Lonn said. "We think it's a chance finding."

The researchers noted that other larger vitamin E trials showed no lung cancer benefit.

Alzheimer's research

There still is some hope that vitamin E might help prevent Alzheimer's disease, although in May a clinical trial of 769 patients with mild cognitive impairment found it was of no benefit in delaying the progression to Alzheimer's.

In that trial, the patients took a mega dose 2,000 IU a day for up to three years, according to the findings in the New England Journal of Medicine.

Other vitamin E / Alzheimer's trials are ongoing.

The anti-oxidant vitamin enthusiasm of the 1990s is being tempered by clinical trials, according to a JAMA editorial that accompanied the Women's Health Study results.

"These hopes are now confined to modest expectations for specific disorders and there are concerns about adverse effects," the editorial said.

Mike Freije from Health Shop
http://www.health-shop.com
http://www.health-shop.info


MORE RESOURCES:

Boston Globe

Salesman Brown pursues a weight-loss constituency
Boston Globe
Brown's testament to the merits of AdvoCare's “24-day challenge” was met with so many guffaws that within two hours, he posted another note, saying he is not a paid spokesman for the supplement company. What he didn't explain is that he's a salesman.
Scott Brown Loses Weight, Pitches Diet, Energy Supplements on FacebookNECN
Scott Brown now hawking Herbalife-style health supplements AdvocareDaily Mail
Scott Browns Newest Campaign: Shady Diet PillsDaily Beast

all 5 news articles »


U.S. News & World Report

Dietary Supplements During Cancer Treatment: Yes or No?
U.S. News & World Report
Is it a good idea to take dietary supplements while going through active cancer treatment? It's a gray area. Some doctors say patients should hold off, at least while undergoing chemotherapy. But some practitioners in complementary or integrative ...



NutraIngredients.com

RCT data questions benefits of vitamin B12 supplements for older people
NutraIngredients.com
The study, published in the American Journal of Clinical Nutrition, reports on a trial of 201 people aged over 75 years with moderate vitamin B12 deficiency who received either vitamin B12 or a placebo supplements for one year – finding no evidence of ...
Benefits of vitamin B12 supplements for older people questionedMedical Xpress
Acne treatment: Decreasing vitamin B12 supplements can help reduce acne ...ChristianToday
Vitamin B12 supplements 'do not benefit cognitive function'Nursing Times
Care Appointments
all 16 news articles »


NutraIngredients-usa.com

Consumers understand micronutrient supplements help fill nutrient gaps, says ...
NutraIngredients-usa.com
The majority of consumers recognize that nutritional supplements can help fill nutrient gaps but should not be viewed as replacements for a healthy diet, according to a new survey conducted on behalf of the Council for Responsible Nutrition (CRN).
Dietary Supplements Market – Global Industry Analysis, Size, Share, Trends ...Medgadget.com (blog)
Consumers understand supplements help fill nutrient gaps, new survey showsMedical Xpress
Public Release: 1-Jul-2015 Consumers understand supplements help fill ...EurekAlert (press release)

all 5 news articles »


Southernminn.com

Multivitamins and supplements: To take or not to take?
Southernminn.com
People ask me this question quite often: “Should I be taking certain vitamins and supplements?” And the answer is, quite honestly, “It depends.” According to the Dietary Guidelines for Americans, you should meet your nutritional needs primarily through ...

and more »


NutraIngredients.com

Norway warns on polluted fish oil supplements
NutraIngredients.com
The Norwegian Food Safety Authority has urged consumers to throw away three 'alternative' fish oil supplements after tests revealed they contained carcinogenic contaminants way over EU safe limits.



Keeping Airmen healthy and informed through Operation Supplement Safety
Edwards Air Force Base
"One third of Airmen report using legal body building supplements and one in six report weight loss supplements in the past year," said Col. (Dr.) John Oh, the chief of health promotion for the Air Force Medical Support Agency. "Body building and ...



New York Times (blog)

Well | Alzheimer's Supplements Targeted by US Senator
New York Times (blog)
A United States Senator this week raised concerns about dietary supplements that claim to protect against dementia and Alzheimer's disease and urged 15 major companies and retailers to explain why they sell dubious supplements. The senator, Claire ...

and more »


U.S. News & World Report

Senator McCaskill questions retailers, search engines about supplements ...
U.S. News & World Report
This is the latest probe into the $30 billion-dollar dietary supplement industry, which encompasses thousands of products and has long been plagued by questionable advertising, marketing and manufacturing practices. Supplements have never been subject ...
Retailers under scrutiny for selling dubious 'brain supplements'Press Herald
Senator probes retailers on dubious 'brain' supplementsKOB.com

all 104 news articles »


Public Release: 30-Jun-2015 Omega-3 supplements and antioxidants may help ...
EurekAlert (press release)
Here's more evidence that fish oil supplementation and antioxidants might be beneficial for at least some people facing Alzheimer's disease: A new report published in the July 2015 issue of The FASEB Journal describes the findings of a very small study ...

and more »

Google News


Advertisement



Section Site Map - Submit News - Feedback - Comments - Advertise with Us

Copyright 2006 Luminati Inc. All rights reserved.